|97.19||-1.23||-1.25%||Vol 3.05M||1Y Perf 6.35%|
|Feb 2nd, 2023 13:39 DELAYED|
|0.39 0.40%||- -|
|Target Price||110.00||Analyst Rating||Moderate Buy 1.75|
|Potential %||13.43||Finscreener Ranking||★ 41.25|
|Insiders Trans % 3/6/12 mo.||-/-71/-78||Value Ranking||★+ 43.47|
|Insiders Value % 3/6/12 mo.||-/-99/-99||Growth Ranking||★★ 44.67|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-99/-99||Income Ranking||★ 30.00|
|Price Range Ratio 52W %||59.22||Earnings Rating||—|
|Market Cap||142.88B||Earnings Date||24th Jan 2023|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.24|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||4.18M|
|Avg. Monthly Volume||5.02M|
|Avg. Quarterly Volume||4.29M|
Raytheon Technologies Corporation (NYSE: RTX) stock closed at 98.42 per share at the end of the most recent trading day (a -1.43% change compared to the prior day closing price) with a volume of 4.81M shares and market capitalization of 142.88B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Aerospace & Defense industry, Industrials sector and employs 181000 people. Raytheon Technologies Corporation CEO is Gregory J. Hayes.
The one-year performance of Raytheon Technologies Corporation stock is 6.35%, while year-to-date (YTD) performance is -2.48%. RTX stock has a five-year performance of %. Its 52-week range is between 80.27 and 108.84, which gives RTX stock a 52-week price range ratio of 59.22%
Raytheon Technologies Corporation currently has a PE ratio of 34.20, a price-to-book (PB) ratio of 2.15, a price-to-sale (PS) ratio of 2.99, a price to cashflow ratio of 27.00, a PEG ratio of 2.32, a ROA of 2.81%, a ROC of 5.32% and a ROE of 6.31%. The company’s profit margin is 7.84%, its EBITDA margin is 16.30%, and its revenue ttm is $48.98 Billion , which makes it $33.32 revenue per share.
Of the last four earnings reports from Raytheon Technologies Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.24 for the next earnings report. Raytheon Technologies Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for Raytheon Technologies Corporation is Moderate Buy (1.75), with a target price of $110, which is +13.43% compared to the current price. The earnings rating for Raytheon Technologies Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Raytheon Technologies Corporation has a dividend yield of 2.21% with a dividend per share of $2.20 and a payout ratio of 114.00%.
Raytheon Technologies Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 15.49, ATR14 : 2.54, CCI20 : -13.54, Chaikin Money Flow : 0.01, MACD : 0.08, Money Flow Index : 42.82, ROC : -0.26, RSI : 49.08, STOCH (14,3) : 32.77, STOCH RSI : 0.00, UO : 46.84, Williams %R : -67.23), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Raytheon Technologies Corporation in the last 12-months were: Amy L. Johnson (Option Excercise at a value of $0), Christopher T. Calio (Option Excercise at a value of $0), Dantaya M. Williams (Option Excercise at a value of $233 725), Dantaya M. Williams (Sold 1 206 shares of value $110 968 ), Gregory J. Hayes (Option Excercise at a value of $5 087 096), Gregory J. Hayes (Sold 4 260 shares of value $422 405 ), James A. Winnefeld (Buy at a value of $19 800), Michael R. Dumais (Option Excercise at a value of $2 241 114), Michael R. Dumais (Sold 14 326 shares of value $1 427 834 ), Neil G. Mitchill (Option Excercise at a value of $0), Ramsaran Maharajh (Option Excercise at a value of $0), Robert K. Ortberg (Option Excercise at a value of $0), Roy Azevedo (Option Excercise at a value of $0), Shane G. Eddy (Option Excercise at a value of $562 076), Shane G. Eddy (Sold 3 343 shares of value $319 347 ), Stephen J. Timm (Option Excercise at a value of $0), Tracy A. Atkinson (Sold 5 340 shares of value $499 992 ), Wesley D. Kremer (Option Excercise at a value of $0), Wesley D. Kremer (Sold 15 083 shares of value $1 416 655 )
Thu, 26 Jan 2023 01:45 GMT Raytheon Technologies (RTX) Receives a Rating Update from a Top Analyst- TipRanks. All rights reserved.
Mon, 28 Nov 2022 11:50 GMT Analysts Offer Insights on Technology Companies: Raytheon Technologies (RTX) and HubSpot (HUBS)- TipRanks. All rights reserved.
Mon, 26 Sep 2022 13:06 GMT Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients- TipRanks. All rights reserved.
Sat, 17 Sep 2022 01:45 GMT New Buy Rating for Raytheon Technologies (RTX), the Technology Giant- TipRanks. All rights reserved.
Wed, 27 Jul 2022 12:12 GMT Raytheon Technologies (RTX) Receives a Buy from J.P. Morgan- TipRanks. All rights reserved.
Wed, 27 Jul 2022 00:05 GMT Raytheon Technologies (RTX) Receives a Buy from Cowen & Co.- TipRanks. All rights reserved.
Fri, 15 Jul 2022 06:47 GMT Heres Why AeroVironment Is the Hottest Stock This Week- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.